Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances
Spremljeno u:
Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances. Serie: Risk Assessments n. 29, Lisboa, European Monitoring Centre for Drugs and Drug Addiction, 2018, 58 p.
Ref.
537973
Lokacija:
SIIS Archivo
Palabras clave:
Drogodependencias, Drogas de síntesis, Acción contra las drogodependencias, Fármacos, Riesgo, Evaluación, Factor de riesgo, Efectos, Salud, Toxicidad, Intoxicación, Mortalidad, Patrones de consumo, Tráfico de drogas, Delincuencia, Unión Europea
Drogodependencias, Drogas de síntesis, Acción contra las drogodependencias, Fármacos, Riesgo, Evaluación, Factor de riesgo, Efectos, Salud, Toxicidad, Intoxicación, Mortalidad, Patrones de consumo, Tráfico de drogas, Delincuencia, Unión Europea
Slični predmeti: Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances
- Methoxyacetylfentanyl. Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide in the framework of the Council Decision on new psychoactive substances
- Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances
- REPORT ON THE RISK ASSESSMENT OF BZP IN THE FRAMEWORK OF THE COUNCIL DECISION ON NEW PSYCHOACTIVE SUBSTANCES
- Poppers
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
- REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS